Kinesio Taping and Manual Therapy Efficacity on Lumbar Pain During Pregnancy

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03324672
Collaborator
(none)
56
1
2
41.3
1.4

Study Details

Study Description

Brief Summary

Pregnant women often suffer from lumbar pain , specially during the last semester . Usually physiotherapy and manual therapy on TRIGGER point help them .

But there is also another type of support , the Kinesio-Taping using the pose of a strip which aims to mobilize the muscle without any restriction.

The purpose is to reduce the pain with the combo therapy (TRIGGER point plus Kinesi Taping)

Condition or Disease Intervention/Treatment Phase
  • Procedure: TRIGGER
  • Procedure: TRIGGER+CURETAPE
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Kinesio Taping and Manual Therapy Efficacity on Lumbar Pain During Pregnancy
Actual Study Start Date :
Jul 24, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: TRIGGER

Procedure: TRIGGER
only TRIGGER point will be included for the manual therapy

Experimental: TRIGGER+CURETAPE

Procedure: TRIGGER+CURETAPE
TRIGGER point will be included for the manual therapy with kinesio-taping

Outcome Measures

Primary Outcome Measures

  1. French version of Roland-Morris questionnaire in chronic low back pain patients EIFEL Échelle d'Incapacité Fonctionnelle pour l'Évaluation des Lombalgies questionnaire) score [change from week 30 to week 38]

    EIFEL questionnaire is filled by patient between week 30 of pregnancy to week 38, scale range from 0 to 24,

Secondary Outcome Measures

  1. Pain scale [change from week 30 to week 38]

    Pain scale is filled by patient between week 30 of pregnancay to week 30, scale range from 0 to 10

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age > 18

  • french speaking

  • single pregnancy

  • lumbar pain

  • EIFEL score>6

  • medical insurance

Exclusion Criteria:
  • twins pregnancy

  • rachial arthrodesis

  • Probable Acrylique allergy

  • Psoriasis or other cutaneous problems

  • circulatory disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

Sponsors and Collaborators

  • Groupe Hospitalier Paris Saint Joseph

Investigators

  • Study Director: AZRIA Elie, MD, GHPSJ

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:
NCT03324672
Other Study ID Numbers:
  • TRIGGER
First Posted:
Oct 30, 2017
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Groupe Hospitalier Paris Saint Joseph
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022